ZA200705469B - Sulfanyl substituted phenyl methanones as glycine transporter (GlyT-1) inhibitors for the reatment of neurological and neuropsychiatric disorders - Google Patents
Sulfanyl substituted phenyl methanones as glycine transporter (GlyT-1) inhibitors for the reatment of neurological and neuropsychiatric disordersInfo
- Publication number
- ZA200705469B ZA200705469B ZA200705469A ZA200705469A ZA200705469B ZA 200705469 B ZA200705469 B ZA 200705469B ZA 200705469 A ZA200705469 A ZA 200705469A ZA 200705469 A ZA200705469 A ZA 200705469A ZA 200705469 B ZA200705469 B ZA 200705469B
- Authority
- ZA
- South Africa
- Prior art keywords
- glyt
- reatment
- neurological
- inhibitors
- substituted phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100066 | 2005-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200705469B true ZA200705469B (en) | 2008-11-26 |
Family
ID=35976714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200705469A ZA200705469B (en) | 2005-01-06 | 2007-07-04 | Sulfanyl substituted phenyl methanones as glycine transporter (GlyT-1) inhibitors for the reatment of neurological and neuropsychiatric disorders |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20060149062A1 (ru) |
| EP (1) | EP1836178A1 (ru) |
| JP (1) | JP2008526795A (ru) |
| KR (1) | KR20070094955A (ru) |
| CN (1) | CN101356163A (ru) |
| AR (1) | AR053659A1 (ru) |
| AU (1) | AU2005324023A1 (ru) |
| BR (1) | BRPI0519744A2 (ru) |
| CA (1) | CA2593453A1 (ru) |
| IL (1) | IL184355A0 (ru) |
| MX (1) | MX2007008190A (ru) |
| NO (1) | NO20073330L (ru) |
| RU (1) | RU2007125380A (ru) |
| TW (1) | TW200635911A (ru) |
| WO (1) | WO2006072435A1 (ru) |
| ZA (1) | ZA200705469B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2131843B1 (en) * | 2007-03-05 | 2011-11-09 | F. Hoffmann-La Roche AG | Process for the synthesis of glyt-1 inhibitors |
| MX2011003312A (es) | 2008-10-09 | 2011-04-26 | Hoffmann La Roche | Derivados de pirrolidina n-bencilo. |
| US8153653B2 (en) * | 2010-06-22 | 2012-04-10 | Hoffmann-La Roche Inc. | Amido-tropane derivatives |
| US9012489B2 (en) * | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| CN103254127B (zh) * | 2013-05-28 | 2015-08-19 | 北京哈三联科技有限责任公司 | 甘氨酸重摄取抑制剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2423847A1 (de) * | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
| DE2611705A1 (de) * | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
| CA2322164A1 (en) * | 1998-03-06 | 1999-09-10 | Ludo Edmond Josephine Kennis | Glycine transport inhibitors |
| WO2001081308A2 (en) * | 2000-04-20 | 2001-11-01 | Nps Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
| JP2006512404A (ja) * | 2002-10-22 | 2006-04-13 | グラクソ グループ リミテッド | Ｈ３受容体リガンドとしてのアリールオキシアルキルアミン誘導体 |
| EA009986B1 (ru) * | 2003-08-11 | 2008-04-28 | Ф. Хоффманн-Ля Рош Аг | Пиперазин с or-замещенной фенильной группой и его применение в качестве ингибиторов glyt1 |
| NZ545613A (en) * | 2003-09-09 | 2009-11-27 | Hoffmann La Roche | 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| NZ545454A (en) * | 2003-09-09 | 2009-11-27 | Hoffmann La Roche | 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
-
2005
- 2005-12-28 EP EP05823987A patent/EP1836178A1/en not_active Withdrawn
- 2005-12-28 BR BRPI0519744-9A patent/BRPI0519744A2/pt not_active IP Right Cessation
- 2005-12-28 AU AU2005324023A patent/AU2005324023A1/en not_active Abandoned
- 2005-12-28 MX MX2007008190A patent/MX2007008190A/es not_active Application Discontinuation
- 2005-12-28 WO PCT/EP2005/014081 patent/WO2006072435A1/en active Search and Examination
- 2005-12-28 CN CNA200580048977XA patent/CN101356163A/zh active Pending
- 2005-12-28 KR KR1020077017952A patent/KR20070094955A/ko active IP Right Grant
- 2005-12-28 CA CA002593453A patent/CA2593453A1/en not_active Abandoned
- 2005-12-28 RU RU2007125380/04A patent/RU2007125380A/ru not_active Application Discontinuation
- 2005-12-28 JP JP2007549823A patent/JP2008526795A/ja active Pending
-
2006
- 2006-01-03 US US11/324,991 patent/US20060149062A1/en not_active Abandoned
- 2006-01-03 TW TW095100182A patent/TW200635911A/zh unknown
- 2006-01-04 AR ARP060100022A patent/AR053659A1/es unknown
-
2007
- 2007-06-29 NO NO20073330A patent/NO20073330L/no not_active Application Discontinuation
- 2007-07-02 IL IL184355A patent/IL184355A0/en unknown
- 2007-07-04 ZA ZA200705469A patent/ZA200705469B/xx unknown
-
2008
- 2008-07-16 US US12/173,886 patent/US20080287455A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101356163A (zh) | 2009-01-28 |
| TW200635911A (en) | 2006-10-16 |
| MX2007008190A (es) | 2007-08-07 |
| IL184355A0 (en) | 2007-10-31 |
| KR20070094955A (ko) | 2007-09-27 |
| AU2005324023A1 (en) | 2006-07-13 |
| WO2006072435A1 (en) | 2006-07-13 |
| RU2007125380A (ru) | 2009-02-20 |
| EP1836178A1 (en) | 2007-09-26 |
| AR053659A1 (es) | 2007-05-16 |
| US20060149062A1 (en) | 2006-07-06 |
| BRPI0519744A2 (pt) | 2009-03-10 |
| JP2008526795A (ja) | 2008-07-24 |
| NO20073330L (no) | 2007-07-20 |
| US20080287455A1 (en) | 2008-11-20 |
| CA2593453A1 (en) | 2006-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200705044B (en) | Bi- and tricyclic substituted phenyl methanones as glycine transporter I (GLYT-1) inhibitors for the treatment of Alzheimer's disease | |
| HK1117507A1 (en) | Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 | |
| IL174075A0 (en) | 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses | |
| TWI372146B (en) | Imidazole compounds for the treatment of neurodegenerative disorders | |
| IL173768A0 (en) | 1-(2-amino-benzol)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses | |
| IL185016A0 (en) | Compounds for the treatment of proliferative disorders | |
| IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
| ZA200700384B (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
| ATE557021T1 (de) | Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens | |
| AP2005003274A0 (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
| IL179732A0 (en) | Novel use of peptide compounds for treting essential tremor and other tremor syndromes | |
| IL189659A0 (en) | Ikk inhibitors for the treatment of endometriosis | |
| EP1658072A4 (en) | Compounds for the Treatment of Neurodegenerative Diseases | |
| ZA200705469B (en) | Sulfanyl substituted phenyl methanones as glycine transporter (GlyT-1) inhibitors for the reatment of neurological and neuropsychiatric disorders | |
| AU2003253130A1 (en) | Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders | |
| EP1653952A4 (en) | OXAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER | |
| ZA200708802B (en) | An improved process for the purification of perindopril | |
| EP1937242A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISEASES AND ADDITIVES | |
| EP1877427A4 (en) | NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | |
| GB0425064D0 (en) | Compounds useful for the treatment of diseases | |
| AP2006003743A0 (en) | Compounds useful for the treatment of diseases | |
| ZA200801707B (en) | IKK inhibitors for the treatment of endometriosis | |
| AU2005901975A0 (en) | Novel peptides and methods for the treatment of inflammatory disorders | |
| AU2005901973A0 (en) | Novel peptides and methods for the treatment of inflammatory disorders |